Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-05-11

Clinical Trial Update: Effectiveness of Statins on Lipid Goal Attainment and Lipid Parameters in PCI Patients

View source ↗

Summary

A clinical trial evaluating the effectiveness of statins on lipid goal attainment in patients undergoing percutaneous coronary intervention has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Statin (statin)

Snippet

Sponsor: AstraZeneca | Conditions: PCI Patients | Status: WITHDRAWN